{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:57:22Z","timestamp":1780505842610,"version":"3.54.1"},"reference-count":28,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cVictor Babes\u201d University of Medicine and Pharmacy, Timisoara, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Background\/Objectives: Retinopathy of Prematurity (ROP) remains a leading cause of vision impairment in premature infants, especially those with Respiratory Distress Syndrome (RDS) necessitating respiratory support. This study aimed to identify correlations between plasma levels of Insulin-like Growth Factor 1 (IGF1) and Tumor Necrosis Factor-alpha (TNF-alpha), and the risk of developing ROP. Additionally, it explored the association of ROP severity grades with plasma levels of glucose, lactate dehydrogenase (LDH), creatin phosphokinase (CPK), and other biomarkers, aiming to uncover predictive markers for ROP risk and severity in this population. Methods: This prospective study included premature neonates admitted with RDS requiring respiratory support, conducted over 18 months at the Neonatal Intensive Care Unit of the Louis Turcanu Emergency Clinical Hospital for Children, Timisoara. Plasma levels of IGF1 and TNF-alpha were measured on days 1 and 14 post-birth, alongside the initial assessment of glucose, LDH, and CPK levels. Results: Significant correlations were observed between lower gestational age and elevated LDH levels on day 7\u201310 (rho = \u22120.341, p = 0.0123) and between TNF-alpha levels at 2 weeks and ROP severity (rho = 0.512, p = 0.0004). Elevated IGF1 levels were protective against ROP, with Beta coefficients of 0.37 (p = 0.0032) for the first collection and 0.32 (p = 0.0028) for the second, suggesting their potential as biomarkers for ROP risk assessment. Higher levels of TNF-alpha at 2 weeks were associated with an increased risk of ROP (Beta = \u22120.45, p = 0.0014), whereas higher IGF1 levels offered protective effects against ROP, with Beta coefficients of 0.37 (p = 0.0032) for the first collection and 0.32 (p = 0.0028) for the second. Elevated LDH levels on day 7\u201310 post-birth were linked to an increased risk of ROP (Beta = 0.29, p = 0.0214). Conclusions: These findings highlight the potential of IGF1 and TNF-alpha as predictive biomarkers for ROP, offering avenues for early intervention and improved management strategies in this high-risk group.<\/jats:p>","DOI":"10.3390\/clinpract14040122","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T18:04:59Z","timestamp":1722535499000},"page":"1515-1528","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting Retinopathy of Prematurity Risk Using Plasma Levels of Insulin-like Growth Factor 1 (IGF1), Tumor Necrosis Factor-Alpha (TNF-Alpha), and Neonatal Parameters"],"prefix":"10.3390","volume":"14","author":[{"given":"Daniela Mariana","family":"Cioboata","sequence":"first","affiliation":[{"name":"Department of Neonatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"},{"name":"Doctoral School Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana Cristina","family":"Costescu","sequence":"additional","affiliation":[{"name":"Department of Neonatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"},{"name":"Doctoral School Department, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniko Maria","family":"Manea","sequence":"additional","affiliation":[{"name":"Department of Neonatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florina Marinela","family":"Doandes","sequence":"additional","affiliation":[{"name":"Department of Neonatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Zaharie","sequence":"additional","affiliation":[{"name":"Department of Neonatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran Laurentiu","family":"Popa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Costescu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florina","family":"Stoica","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Emergency Municipal Clinical Hospital, 300172 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marioara","family":"Boia","sequence":"additional","affiliation":[{"name":"Department of Neonatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0974-9233.97927","article-title":"Retinopathy of prematurity: A study of prevalence and risk factors","volume":"19","author":"Hakeem","year":"2012","journal-title":"Middle East. Afr. J. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5409\/wjcp.v5.i1.35","article-title":"Retinopathy of prematurity: Past, present and future","volume":"5","author":"Shah","year":"2016","journal-title":"World J. Clin. Pediatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2147\/IJGM.S401122","article-title":"Latest Trends in Retinopathy of Prematurity: Research on Risk Factors, Diagnostic Methods and Therapies","volume":"16","author":"Tiutiuca","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/sjopt.sjopt_18_22","article-title":"Pathophysiology of retinopathy of prematurity","volume":"36","author":"Strube","year":"2022","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ka\u0161telan, S., Ore\u0161kovi\u0107, I., Bi\u0161\u0107an, F., Ka\u0161telan, H., and Gverovi\u0107 Antunica, A. (2020). Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem. Med., 30.","DOI":"10.11613\/BM.2020.030502"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wu, P.Y., Fu, Y.K., Lien, R.I., Chiang, M.C., Lee, C.C., Chen, H.C., Hsueh, Y.J., Chen, K.J., Wang, N.K., and Liu, L. (2023). Systemic Cytokines in Retinopathy of Prematurity. J. Pers. Med., 13.","DOI":"10.3390\/jpm13020291"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Koliaki, C., and Katsilambros, N. (2022). Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063225"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.earlhumdev.2016.09.008","article-title":"IGF-1 in retinopathy of prematurity, a CNS neurovascular disease","volume":"102","author":"Liegl","year":"2016","journal-title":"Early Hum. Dev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41582-020-0362-2","article-title":"Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: Challenges and opportunities","volume":"16","author":"Davis","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bor\u021bea, C.I., Enatescu, I., Dima, M., Pantea, M., Iacob, E.R., Dumitru, C., Popescu, A., Stoica, F., Heredea, R.E., and Iacob, D. (2023). A Prospective Analysis of the Retinopathy of Prematurity Correlated with the Inflammatory Status of the Extremely Premature and Very Premature Neonates. Diagnostics, 13.","DOI":"10.3390\/diagnostics13122105"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.12659\/MSM.890688","article-title":"Incidence of retinopathy of prematurity in southwestern China and analysis of risk factors","volume":"20","author":"Liu","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mjafi.2019.04.001","article-title":"Hyperglycaemia as a risk factor for the development of retinopathy of prematurity: A cohort study","volume":"76","author":"Vannadil","year":"2020","journal-title":"Med. J. Armed Forces India"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bor\u021bea, C.I., Stoica, F., Boia, M., Iacob, E.R., Dinu, M., Iacob, R., and Iacob, D. (2021). Risk Factors Associated with Retinopathy of Prematurity in Very and Extremely Preterm Infants. Medicina, 57.","DOI":"10.3390\/medicina57050420"},{"key":"ref_14","first-page":"45","article-title":"Retinopathy of prematurity: It is time to take action","volume":"30","author":"Gilbert","year":"2017","journal-title":"Community Eye Health"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yucel, O.E., Eraydin, B., Niyaz, L., and Terzi, O. (2022). Incidence and risk factors for retinopathy of prematurity in premature, extremely low birth weight and extremely low gestational age infants. BMC Ophthalmol., 22.","DOI":"10.1186\/s12886-022-02591-9"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ballot, D.E., Chirwa, T.F., and Cooper, P.A. (2010). Determinants of survival in very low birth weight neonates in a public sector hospital in Johannesburg. BMC Pediatr., 10.","DOI":"10.1186\/1471-2431-10-30"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41372-019-0357-2","article-title":"Prenatal and postnatal inflammation-related risk factors for retinopathy of prematurity","volume":"39","author":"Goldstein","year":"2019","journal-title":"J. Perinatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bollani, L., Auriti, C., Achille, C., Garofoli, F., De Rose, D.U., Meroni, V., Salvatori, G., and Tzialla, C. (2022). Congenital Toxoplasmosis: The State of the Art. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.894573"},{"key":"ref_19","unstructured":"Brown, A.C., and Nwanyanwu, K. (2024, February 12). Retinopathy of Prematurity, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562319\/."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41433-021-01392-6","article-title":"Aggressive posterior retinopathy of prematurity: A review on current understanding","volume":"35","author":"Kumawat","year":"2021","journal-title":"Eye"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s10753-022-01680-7","article-title":"The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients","volume":"45","author":"Gupta","year":"2022","journal-title":"Inflammation"},{"key":"ref_22","first-page":"392","article-title":"Evaluation of total LDH and its isoenzymes as markers in preeclampsia","volume":"39","author":"Saleem","year":"2020","journal-title":"J. Med. Biochem."},{"key":"ref_23","first-page":"e140363","article-title":"IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants","volume":"5","author":"Cakir","year":"2020","journal-title":"J. Clin. Insight"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Mu\u00f1uzuri, A., L\u00f3pez-Su\u00e1rez, O., Mandi\u00e1-Rodr\u00edguez, N., L\u00f3pez-Sanguos, C., Blanco-Teijeiro, M.J., and Couce, M.L. (2020). Validation of an IGF1 Screening Method for Retinopathy of Pre-maturity. Front. Pediatr., 8.","DOI":"10.3389\/fped.2020.615716"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/IAE.0000000000001247","article-title":"Postnatal Serum Insulin-Like Growth Factor I and Retinopathy of Prematurity","volume":"37","author":"Jensen","year":"2017","journal-title":"Retina"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/jrms.JRMS_501_20","article-title":"How is insulin-like growth factor-1 correlated with retinopathy of prematurity?","volume":"26","author":"Jafari","year":"2021","journal-title":"J. Res. Med. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tan, W., Li, B., Wang, Z., Zou, J., Jia, Y., Yoshida, S., and Zhou, Y. (2022). Novel Potential Biomarkers for Retinopathy of Prematurity. Front. Med., 9.","DOI":"10.3389\/fmed.2022.840030"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ghir.2017.11.006","article-title":"Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity","volume":"39","author":"Hellgren","year":"2018","journal-title":"Growth Horm. IGF Res."}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/14\/4\/122\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:28:29Z","timestamp":1760110109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/14\/4\/122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["clinpract14040122"],"URL":"https:\/\/doi.org\/10.3390\/clinpract14040122","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}